Ghent University Academic Bibliography

Your filters: cql: author="Borenäs, Marcus" or (type any "bookEditor issueEditor" and editor="Borenäs, Marcus")

Add to list
- Journal Article
- A1
- open access
RUVBL1 and RUVBL2 are druggable MYC effector regulators in neuroblastoma cells

Joachim Siaw (UGent) , Arne Claeys (UGent) , Wei-Yun Lai, Marcus Borenäs, Elien Hilgert (UGent) , Sarah-Lee Bekaert (UGent) , Ellen Sanders (UGent) , Irem Kaya (UGent) , Jo Van Dorpe (UGent) , Franki Speleman (UGent) , et al.

(2026) ISCIENCE.
Add to list
- Journal Article
- A1
- open access
Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions

Joachim Siaw (UGent) , Peter Merseburger (UGent) , Marcus Borenäs, Caroline Jansson, Jenny Karlsson, Arne Claeys (UGent) , Eva Jennische, Dan E Lind, David Gisselsson Nord, Ruth H Palmer, et al.

(2025) JOURNAL OF PATHOLOGY. 267(2). p.181-195
Add to list
- Miscellaneous
ALK/ATR combination therapy is effective in neuroblastoma mouse tumors driven by MYCN

Marcus Borenas, Dan Lind, Adam Lehnberg, Edit Zentenius, Matilda Esselius, Eva Jennische, Joel Johansson, Jikui Guan, Agata Aniszewska, Jimmy Van den Eynden (UGent) , et al.

(2025) bioRxiv.
Add to list
- Journal Article
- A1
- open access
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition

Marcus Borenäs, Ganesh Umapathy, Dan E. Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan Linus Gabre (UGent) , et al.

(2024) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 121(1).
Add to list
- Journal Article
- A1
- open access
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation

Marcus Borenäs, Ganesh Umapathy, Wei‐Yun Lai, Dan E Lind, Barbara Witek, Jikui Guan, Patricia Mendoza‐Garcia, Tafheem Masudi, Arne Claeys (UGent) , Tzu‐Po Chuang, et al.

(2021) EMBO JOURNAL. 40(3).

Academic Bibliography

RUVBL1 and RUVBL2 are druggable MYC effector regulators in neuroblastoma cells

Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions

ALK/ATR combination therapy is effective in neuroblastoma mouse tumors driven by MYCN

ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition

ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation

Contents

Support

Contact